骨关节炎的新疗法:基因疗法
Xinyu Li1, Leyao Shen2, Zhenghan Deng3
1Department of Orthopaedic Surgery, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, China.
Precision clinical medicine
|June 19, 2023
概括
基因疗法为骨关节炎提供了一种有前途的非手术治疗方法,旨在延迟疾病的进展和修复软骨. 本综述探讨了基因治疗载体,基因标,传递方法以及CRISPR/Cas9在关节炎治疗中的应用.
科学领域:
- 生物医学工程 生物医学工程
- 再生医学是一种再生医学.
- 整形外科 整形外科 整形外科
背景情况:
- 骨关节炎 (OA) 是一种退行性关节疾病,目前的非手术治疗主要集中在缓解疼痛.
- 关节塑造术是末期OA的一个选择,但高成本需要替代治疗来延迟进展并促进软骨修复.
- 基因疗法为在关节内的特定部位持续治疗性蛋白质表达提供了一种新的方法.
研究的目的:
- 审查当前的基因治疗骨关节炎的现状.
- 概述OA基因治疗中使用的常见表达载体,基因标和传递方法.
- 讨论CRISPR/Cas9基因编辑技术的潜力以及OA临床翻译方面的挑战.
主要方法:
- 对基因疗法在骨关节炎中的应用现有文献的综述.
- 分析常见的基因疗法组件:表达载体 (病毒和非病毒),传递的基因 (转录因子,生长因子,细胞因子,ncRNA) 和传递方式 (直接和间接).
- 探索CRISPR/Cas9技术在OA治疗中的作用和前景.
主要成果:
- 基因疗法利用各种载体和基因标来实现骨关节炎的治疗效果.
- 采用不同的输送方法,正在进行优化疗效和安全性的研究.
- 在OA中,CRISPR/Cas9技术显示出精确基因编辑的巨大潜力,尽管临床翻译面临障碍.
结论:
- 基因疗法为传统的疼痛管理和骨关节炎的侵入性手术提供了可行的替代方案.
- 了解载体,基因和传递系统对于推进OA基因治疗至关重要.
- 解决临床翻译方面的挑战是实现基因治疗和骨关节炎基因编辑的全部潜力的关键.
相关概念视频
00:59Gene Therapy
25.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.6K
01:21Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
204
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
204
01:24Parkinson's Disease: Treatment
303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303
01:22Alzheimer's Disease: Treatment
223
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
223
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
177
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
177